SCHEMBL7227121

SCHEMBL7227121

NC(=O)CNC(=O)COc1ccc(S(=O)(=O)Cl)cc1.NC(=O)CNC(=O)COc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.55
HTT P42858 2/20 0.50
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
HPGD P15428 2/20 0.49
ALDH1A1 P00352 4/20 0.47
PKM P14618 3/20 0.47
NPC1 O15118 2/20 0.47
SGMS1 Q86VZ5 1/20 0.47
RECQL P46063 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
RAB9A P51151 2/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7012916 0.95 POLB (0.47) POLBHTTKMT2AMEN1ALDH1A1
SCHEMBL1695673 0.86 KMT2A (0.63) POLBHTTKMT2AMEN1HPGD
SCHEMBL7227128 0.80 TARS1 (0.40) KMT2AMEN1HPGDALDH1A1
SCHEMBL5367144 0.79 ALDH1A1 (0.51) POLBKMT2AMEN1ALDH1A1RAB9A
SCHEMBL5316483 0.77 ALDH1A1 (0.73) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL27995932 0.75 LMNA (0.57) HTTKMT2AMEN1HPGDALDH1A1
SCHEMBL11393650 0.74 KMT2A (0.63) POLBHTTKMT2AMEN1HPGD
SCHEMBL7821754 0.74 ALOX15 (0.68) POLBHTTKMT2AMEN1HPGD
SCHEMBL7009381 0.73 KMT2A (0.62) POLBKMT2AMEN1HPGDALDH1A1
SCHEMBL11775788 0.72 KMT2A (0.69) POLBHTTKMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6559167-B1 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-05-06 US disclosed
EP-1105387-A1 PRODRUGS OF PROTON PUMP INHIBITORS Partnership of Michael E. Garst, George Sachs and Jai Moo Shin (US) 2001-06-13 EP disclosed
WO-2000009498-A1 PRODRUGS OF PROTON PUMP INHIBITORS PARTNERSHIP OF MICHAEL E. GARST, GEORGE SACHS AND JAI MOO SHIN (US) 2000-02-24 WO disclosed